THE ROLE OF THE MACROPHAGE IN LUNG DISEASE MEDIATED BY BACTERIA

REFERENCES

• Johanson WG, Pierce AK, Sanford JP: Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli. N Engl J Med. 1969;281:1137–1140.
   PubMed Web of Science ®Google Scholar
• Lim WS, Macfarlane JT, Boswell TC, Harrison TG, Rose D, Leinonen M, Saikku P: Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax. 2001;56:296–301.
   PubMed Web of Science ®Google Scholar
• Parsons HK, Tomlin K, Metcalf SC, Brazier JE, Dockrell DH: The economic cost of invasive pneumococcal disease and the potential for reduction by vaccination in an adult population in South Yorkshire. Q J Med. 2006;99:348–349.
   Google Scholar
• Marfin AA, Sporrer J, Moore PS, Siefkin AD: Risk factors for adverse outcome in persons with pneumococcal pneumonia. Chest. 1995;107:457–462.
   PubMed Web of Science ®Google Scholar
• McCullers JA: Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev. 2006;19:571–582.
   PubMed Web of Science ®Google Scholar
• Aziz MA, Wright A: The world health organization/international union against tuberculosis and lung disease global project on surveillance for anti-tuberculosis drug resistance: a model for other infectious diseases. Clin Infect Dis. 2005;41(Suppl 4):S258–S262.
   PubMed Web of Science ®Google Scholar
• Wagner JG, Roth RA: Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. Pharmacol Rev. 2000;52:349–374.
   PubMed Web of Science ®Google Scholar
• Haslett C: Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am J Respir Crit Care Med. 1999;160(5 Pt 2):S5–S11.
   PubMed Web of Science ®Google Scholar
• Wallace JM, Hansen NI, Lavange L, Glassroth J, Browdy BL, Rosen MJ, Kvale PA, Mangura BT, Reichman LB, Hopewell PC: Respiratory disease trends in the pulmonary complications of HIV infection study cohort. Pulmonary complications of HIV infection study group. Am J Respir Crit Care Med. 1997;155:72–80.
   PubMed Web of Science ®Google Scholar
• Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, Kapoor WN: Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA. 1996;275:134–141.
   PubMed Web of Science ®Google Scholar
• Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334–1349.
   PubMed Web of Science ®Google Scholar
• Johnston RB Jr: Pathogenesis of pneumococcal pneumonia. Rev Infect Dis. 1991;13(Suppl 6):S509–S517.
   PubMedGoogle Scholar
• Dheda K, Booth H, Huggett JF, Johnson MA, Zumla A, Rook GA: Lung remodeling in pulmonary tuberculosis. J Infect Dis. 2005;192:1201–1209.
   PubMed Web of Science ®Google Scholar
• File TM: Community-acquired pneumonia. Lancet. 2003;362:1991–2001.
   PubMed Web of Science ®Google Scholar
• Berkley JA, Lowe BS, Mwangi I, Williams T, Bauni E, Mwarumba S, Ngetsa C, Slack MP, Njenga S, Hart CA, Maitland K, English M, Marsh K, Scott JA: Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med. 2005;352:39–47.
   PubMed Web of Science ®Google Scholar
• Bogaert D, De Groot R, Hermans PW: Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis. 2004;4:144–154.
   PubMed Web of Science ®Google Scholar
• Grijalva CG, Nuorti JP, Arbogast PG, Martin SW, Edwards KM, Griffin MR: Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet. 2007;369:1179–1186.
   PubMed Web of Science ®Google Scholar
• Kadioglu A, Andrew PW: The innate immune response to pneumococcal lung infection: the untold story. Trends Immunol. 2004;25:143–149.
   PubMed Web of Science ®Google Scholar
• Kadioglu A, Coward W, Colston MJ, Hewitt CR, Andrew PW: CD4-T-lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection. Infect Immun. 2004;72:2689–2697.
   PubMed Web of Science ®Google Scholar
• Colino J, Shen Y, Snapper CM: Dendritic cells pulsed with intact Streptococcus pneumoniae elicit both protein- and polysaccharide-specific immunoglobulin isotype responses in vivo through distinct mechanisms. J Exp Med. 2002;195:1–13.
   PubMed Web of Science ®Google Scholar
• Picard C, Puel A, Bustamante J, Ku CL, Casanova JL: Primary immunodeficiencies associated with pneumococcal disease. Curr Opin Allergy Clin Immunol. 2003;3:451–459.
   PubMed Web of Science ®Google Scholar
• Ratner AJ, Aguilar JL, Shchepetov M, Lysenko ES, Weiser JN: Nod1 mediates cytoplasmic sensing of combinations of extracellular bacteria. Cell Microbiol. 2007;9:1343–1351.
   PubMed Web of Science ®Google Scholar
• Jones MR, Simms BT, Lupa MM, Kogan MS, Mizgerd JP: Lung NF-kappaB activation and neutrophil recruitment require IL-1 and TNF receptor signaling during pneumococcal pneumonia. J Immunol. 2005;175:7530–7535.
   PubMed Web of Science ®Google Scholar
• Rubins JB, Pomeroy C: Role of gamma interferon in the pathogenesis of bacteremic pneumococcal pneumonia. Infect Immun. 1997;65:2975–2977.
   PubMed Web of Science ®Google Scholar
• Rijneveld AW, van den Dobbelsteen GP, Florquin S, Standiford TJ, Speelman P, van Alphen L, van der Poll T: Roles of interleukin-6 and macrophage inflammatory protein-2 in pneumolysin-induced lung inflammation in mice. J Infect Dis. 2002;185:123–126.
   PubMed Web of Science ®Google Scholar
• Sun K, Salmon SL, Lotz SA, Metzger DW: Interleukin-12 promotes gamma interferon-dependent neutrophil recruitment in the lung and improves protection against respiratory Streptococcus pneumoniae infection. Infect Immun. 2007;75:1196–1202.
   PubMed Web of Science ®Google Scholar
• Lauw FN, Branger J, Florquin S, Speelman P, van Deventer SJ, Akira S, van der Poll T: IL-18 improves the early antimicrobial host response to pneumococcal pneumonia. J Immunol. 2002;168:372–378.
   PubMed Web of Science ®Google Scholar
• Knapp S, Wieland CW, van 't Veer C, Takeuchi O, Akira S, Florquin S, van der Poll TP: Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense. J Immunol. 2004;172:3132–3138.
   PubMed Web of Science ®Google Scholar
• Malley R, Henneke P, Morse SC, Cieslewicz MJ, Lipsitch M, Thompson CM, Kurt-Jones E, Paton JC, Wessels MR, Golenbock DT: Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci USA. 2003;100:1966–1971.
   PubMed Web of Science ®Google Scholar
• Opitz B, Puschel A, Schmeck B, Hocke AC, Rosseau S, Hammerschmidt S, Schumann RR, Suttorp N, Hippenstiel S: Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae. J Biol Chem. 2004;279:36426–36432.
   PubMed Web of Science ®Google Scholar
• Khor CC, Chapman SJ, Vannberg FO, Dunne A, Murphy C, Ling EY, Frodsham AJ, Walley AJ, Kyrieleis O, Khan A, Aucan C, Segal S, Moore CE, Knox K, Campbell SJ, Lienhardt C, Scott A, Aaby P, Sow OY, Grignani RT, Sillah J, Sirugo G, Peshu N, Williams TN, Maitland K, Davies RJ, Kwiatkowski DP, Day NP, Yala D, Crook DW, Marsh K, Berkley JA, O'Neill LA, Hill AV: A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet. 2007;39:523–528.
   PubMed Web of Science ®Google Scholar
• Dockrell DH, Marriott HM, Prince LR, Ridger VC, Ince PG, Hellewell PG, Whyte MK: Alveolar macrophage apoptosis contributes to pneumococcal clearance in a resolving model of pulmonary infection. J Immunol. 2003;171:5380–5388.
   PubMed Web of Science ®Google Scholar
• Coggon D, Inskip H, Winter P, Pannett B: Lobar pneumonia: an occupational disease in welders. Lancet. 1994;344:41–43.
   PubMed Web of Science ®Google Scholar
• Antonini JM, Leonard SS, Roberts JR, Solano-Lopez C, Young SH, Shi X, Taylor MD: Effect of stainless steel manual metal arc welding fume on free radical production, DNA damage, and apoptosis induction. Mol Cell Biochem. 2005;279:17–23.
   PubMed Web of Science ®Google Scholar
• Knapp S, Leemans JC, Florquin S, Branger J, Maris NA, Pater J, van Rooijen N, van der Poll T: Aveolar l macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia. Am J Respir Crit Care Med. 2003;167:171–179.
   PubMed Web of Science ®Google Scholar
• van oud Alblas AB, van Furth R: Origin, Kinetics, and characteristics of pulmonary macrophages in the normal steady state. J Exp Med. 1979;149:1504–1518.
   PubMed Web of Science ®Google Scholar
• Thomas ED, Ramberg RE, Sale GE, Sparkes RS, Golde DW: Direct evidence for a bone marrow origin of the alveolar macrophage in man. Science. 1976;192:1016–1018.
   PubMed Web of Science ®Google Scholar
• Blusse van Oud Alblas A, van der Linden-Schrever B, van Furth R: Origin and kinetics of pulmonary macrophages during an inflammatory reaction induced by intravenous administration of heat-killed bacillus Calmette-Guérin. J Exp Med. 1981;154:235–252.
   PubMed Web of Science ®Google Scholar
• Liu H, Perlman H, Pagliari LJ, Pope RM: Constitutively activated Akt-1 is vital for the survival of human monocyte-differentiated macrophages. Role of Mcl-1, independent of nuclear factor (NF)-kappaB, Bad, or caspase activation. J Exp Med. 2001;194:113–126.
   Google Scholar
• Perlman H, Pagliari LJ, Georganas C, Mano T, Walsh K, Pope RM: FLICE-inhibitory protein expression during macrophage differentiation confers resistance to fas-mediated apoptosis. J Exp Med. 1999;190:1679–1688.
   PubMed Web of Science ®Google Scholar
• Pagliari LJ, Perlman H, Liu H, Pope RM: Macrophages require constitutive NF-kappaB activation to maintain A1 expression and mitochondrial homeostasis. Mol Cell Biol. 2000;20:8855–8865.
   PubMed Web of Science ®Google Scholar
• Franke-Ullmann G, Pfortner C, Walter P, Steinmuller C, Lohmann-Matthes ML, Kobzik L: Characterization of murine lung interstitial macrophages in comparison with alveolar macrophages in vitro. J Immunol. 1996;157:3097–3104.
   PubMed Web of Science ®Google Scholar
• Jonsson S, Musher DM, Chapman A, Goree A, Lawrence EC: Phagocytosis and killing of common bacterial pathogens of the lung by human alveolar macrophages. J Infect Dis. 1985;152:4–13.
   PubMed Web of Science ®Google Scholar
• Gordon SB, Irving GR, Lawson RA, Lee ME, Read RC: Intracellular trafficking and killing of Streptococcus pneumoniae by human alveolar macrophages are influenced by opsonins. Infect Immun. 2000;68:2286–2293.
   PubMed Web of Science ®Google Scholar
• Hickman-Davis JM, O'Reilly P, Davis IC, Peti-Peterdi J, Davis G, Young KR, Devlin RB, Matalon S: Killing of Klebsiella pneumoniae by human alveolar macrophages. Am J Physiol Lung Cell Mol Physiol. 2002;282:L944–L956.
   PubMed Web of Science ®Google Scholar
• Marriott HM, Ali F, Read RC, Mitchell TJ, Whyte MK, Dockrell DH: Nitric oxide levels regulate macrophage commitment to apoptosis or necrosis during pneumococcal infection. FASEB J. 2004;18:1126–1128.
   PubMed Web of Science ®Google Scholar
• Kerr AR, Wei XQ, Andrew PW, Mitchell TJ: Nitric oxide exerts distinct effects in local and systemic infections with Streptococcus pneumoniae. Microb Pathog. 2004;36:303–310.
   PubMed Web of Science ®Google Scholar
• Marriott HM, Hellewell PG, Whyte MK, Dockrell DH: Contrasting roles for reactive oxygen species and nitric oxide in the innate response to pulmonary infection with Streptococcus pneumoniae. Vaccine. 2007;25:2485–2490.
   PubMed Web of Science ®Google Scholar
• Lekstrom-Himes JA, Gallin JI: Immunodeficiency diseases caused by defects in phagocytes. N Engl J Med. 2000;343:1703–1714.
   PubMed Web of Science ®Google Scholar
• Jennings JH, Linderman DJ, Hu B, Sonstein J, Curtis JL: Monocytes recruited to the lungs of mice during immune inflammation ingest apoptotic cells poorly. Am J Respir Cell Mol Biol. 2005;32:108–117.
   PubMed Web of Science ®Google Scholar
• Badley AD, Dockrell D, Simpson M, Schut R, Lynch DH, Leibson P, Paya CV: Macrophage-dependent apoptosis of CD4 + T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J Exp Med. 1997;185:55–64.
   PubMed Web of Science ®Google Scholar
• Meszaros AJ, Reichner JS, Albina JE: Macrophage-induced neutrophil apoptosis. J Immunol. 2000;165:435–441.
   PubMed Web of Science ®Google Scholar
• Dockrell DH, Lee M, Lynch DH, Read RC: Immune-mediated phagocytosis and killing of Streptococcus pneumoniae are associated with direct and bystander macrophage apoptosis. J Infect Dis. 2001;184:713–722.
   PubMed Web of Science ®Google Scholar
• Zychlinsky A, Sansonetti P: Perspectives series: host/pathogen interactionApoptosis s in bacterial pathogenesis. J Clin Invest. 1997;100(3):493–495.
   PubMed Web of Science ®Google Scholar
• Zychlinsky A, Prevost MC, Sansonetti PJ: Shigella flexneri induces apoptosis in infected macrophages. Nature. 1992;358:167–169.
   PubMed Web of Science ®Google Scholar
• Monack DM, Raupach B, Hromockyj AE, Falkow S: Salmonella typhimurium invasion induces apoptosis in infected macrophages. Proc Natl Acad Sci USA. 1996;93:9833–9838.
   PubMed Web of Science ®Google Scholar
• Monack DM, Mecsas J, Ghori N, Falkow S: Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death. Proc Natl Acad Sci USA. 1997;94:10385–10390.
   PubMed Web of Science ®Google Scholar
• Ali F, Lee ME, Iannelli F, Pozzi G, Mitchell TJ, Read RC, Dockrell DH: Streptococcus pneumoniae-associated human macrophage apoptosis after bacterial internalization via complement and Fcgamma receptors correlates with intracellular bacterial load. J Infect Dis. 2003;188:1119–1131.
   PubMed Web of Science ®Google Scholar
• Marriott HM, Bingle CD, Read RC, Braley KE, Kroemer G, Hellewell PG, Craig RW, Whyte MK, Dockrell DH: Dynamic changes in Mcl-1 expression regulate macrophage viability or commitment to apoptosis during bacterial clearance. J Clin Invest. 2005;115:359–368.
   PubMed Web of Science ®Google Scholar
• Marriott HM, Hellewell PG, Cross SS, Ince PG, Whyte MK, Dockrell DH: Decreased alveolar macrophage apoptosis is associated with increased pulmonary inflammation in a murine model of pneumococcal pneumonia. J Immunol. 2006;177:6480–6488.
   PubMed Web of Science ®Google Scholar
• Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM: Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest. 1998;101:890–898.
   PubMed Web of Science ®Google Scholar
• Lammas DA, Stober C, Harvey CJ, Kendrick N, Panchalingam S, Kumararatne DS: ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors. Immunity. 1997;7:433–444.
   PubMed Web of Science ®Google Scholar
• Sly LM, Hingley-Wilson SM, Reiner NE, McMaster WR: Survival of Mycobacterium tuberculosis in host macrophages involves resistance to apoptosis dependent upon induction of antiapoptotic Bcl-2 family member Mcl-1. J Immunol. 2003;170:430–437.
   PubMed Web of Science ®Google Scholar
• Keane J, Balcewicz-Sablinska MK, Remold HG, Chupp GL, Meek BB, Fenton MJ, Kornfeld H: Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect Immun. 1997;65:298–304.
   PubMed Web of Science ®Google Scholar
• Gao LY, Abu Kwaik Y: Activation of caspase 3 during Legionella pneumophila-induced apoptosis. Infect Immun. 1999;67:4886–4894.
   PubMed Web of Science ®Google Scholar